|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02373 BEAUTYFARM MED
Nominal 
17.020 -0.180 (-1.047%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 2,145,068 | 31.164% | 1,635,414 | 1,780,740 | 1,503,296 | 1,404,752 |
| Cost of Sales | (1,167,966) | 27.289% | (917,572) | (946,954) | (803,272) | (696,411) |
| Gross Profit | 977,102 | 36.117% | 717,842 | 833,786 | 700,024 | 708,341 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (796) | 413.548% | (155) | (1,306) | 2,015 | 4,571 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (51) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 288,269 | 120.938% | 130,475 | 255,102 | 188,531 | 179,763 | |
| Taxation | (58,130) | 191.481% | (19,943) | (46,761) | (36,346) | (32,340) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (14,482) | 95.096% | (7,423) | (14,866) | (1,226) | (7,094) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 215,657 | 109.154% | 103,109 | 193,475 | 150,959 | 140,329 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 2,974 | -86.244% | 21,619 | 22,933 | 24,794 | 26,418 |
| Depreciation & Amortisation | 331,736 | 11.605% | 297,241 | 275,188 | 259,249 | 223,657 |
| Directors' Emoluments | 3,244 | -47.028% | 6,124 | 4,381 | 1,754 | 2,870 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 94.000 | 80.769% | 52.000 | -- | -- | -- |
| DPS (cts) | 43.000 | -- | 34.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | 45.745% | -- | 65.385% | -- | -- | -- |
| Cash flow per share ($) | 2.736 | -- | 1.911 | -- | -- | -- |
| NBV per share ($) | 3.392 | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 115,421 |
| %Change | 3.211% |
| EPS / (LPS) | RMB 0.500 |
| NBV Per Share (¥) | RMB 3.518 |